French rainmaker Maris breaks up with boutique partner Messier
FILE PHOTO: People ride bicycles on a bike path on the banks of the river Seine with the Pont Rouelle bridge and the Eiffel tower in the background in Paris during the outbreak coronavirus disease (COVID-19) in France, May 14, 2020. REUTERS/Gonzalo Fuente
Get Alerts VIE Hot Sheet
Join SI Premium – FREE
By Pamela Barbaglia
LONDON (Reuters) - Star banker Erik Maris is in the process of leaving investment banking boutique Messier Maris & Associés after a power struggle with partner Jean-Marie Messier, two sources with knowledge of the matter told Reuters.
The 56-year Frenchman has decided to quit the firm which he co-founded in 2010 with Messier, a former chairman and CEO of Vivendi, the sources said, speaking on condition of anonymity as the matter is confidential.
Maris did not immediately respond to a request for comment.
His departure comes after Italian bank Mediobanca
Maris has yet to hand in his resignation to Mediobanca and formalise his decision, they said.
Mediobanca declined to comment.
The sources said Maris intends to move on after disagreements with Messier over strategy and management, as he no longer sees a future for himself at the firm.
The pair built Messier Maris & Associés into France's most successful M&A boutique, advising on more than 200 transactions including Veolia's (NASDAQ: VIE) recent takeover bid for French utility Suez (OTC: SEVI).
A former Lazard banker, Maris is a popular rainmaker in France where he recently represented carmaker Peugeot
He started his career at Morgan Stanley and spent almost two decades at Lazard where he rose to become co-head of the bank's French franchise.
(Reporting by Pamela Barbaglia in London; Additional reporting by Gwenaelle Barzic in Paris; Editing by Matthew Lewis)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Morgan Stanley Starts Sampo Oyj (SAMPO:FH) (SAXPY) at Equalweight
- NextEra Energy (NEE) PT Raised to $94 at Jefferies
- AstraZeneca licenses sunvozertinib from Dizal for $600M upfront
Create E-mail Alert Related Categories
ReutersRelated Entities
Chrysler LLC, Morgan Stanley, Lazard, Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share